Search results for "Pregnancy complications"

showing 10 items of 490 documents

Proteinuria-Microalbuminuria in Renal Damage

2015

Proteinuria (P) usually results from an insult in the glomerular and/or tubular structures of the kidney. It has been considered a marker of risk not only to develop renal insufficiency but also to suffer cardiovascular events, based on prospective studies carried out in the general population as well as in diabetic and hypertensive patients [1]. In fact, proteinuria has been considered a strong marker of risk and an intermediate endpoint during treatment [2, 3].

education.field_of_studymedicine.medical_specialtyKidneyProteinuriaurogenital systemRenal damagebusiness.industryPopulationUrologyIntermediate endpointurologic and male genital diseasesmedicine.diseasefemale genital diseases and pregnancy complicationsSpot urinemedicine.anatomical_structuremedicineMicroalbuminuriamedicine.symptomeducationbusinessProspective cohort study
researchProduct

Additional file 1: of Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients

2016

Figure S1. Correlation of platinum sensitivity status with survival. Kaplan Meier curves of EOC patients grouped according to platinum sensitive (PS) or resistant (PR) disease. Patients with a platinum sensitive ovarian cancer presents a significant longer survival thus confirming the reliability of the sample. (JPG 182 kb)

endocrine system diseasesfemale genital diseases and pregnancy complications
researchProduct

Additional file 4: of Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BR…

2016

Pathology of BRCA1 and BRCA2 MBCs and ORs in predicting BRCA2 mutation carrier status. (DOCX 20 kb)

endocrine system diseasespolycyclic compoundsskin and connective tissue diseasesneoplasmsfemale genital diseases and pregnancy complications3. Good health
researchProduct

Additional file 4: of Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BR…

2016

Pathology of BRCA1 and BRCA2 MBCs and ORs in predicting BRCA2 mutation carrier status. (DOCX 20 kb)

endocrine system diseasespolycyclic compoundsskin and connective tissue diseasesneoplasmsfemale genital diseases and pregnancy complications3. Good health
researchProduct

Additional file 1: of Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BR…

2016

Male BRCA1 and BRCA2 mutation carriers by study group/country. (DOCX 21 kb)

endocrine system diseasesskin and connective tissue diseasesneoplasmsfemale genital diseases and pregnancy complications3. Good health
researchProduct

Additional file 1: of Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BR…

2016

Male BRCA1 and BRCA2 mutation carriers by study group/country. (DOCX 21 kb)

endocrine system diseasesskin and connective tissue diseasesneoplasmsfemale genital diseases and pregnancy complications3. Good health
researchProduct

Serum inhibin A, inhibin B, pro-alphaC, and activin A levels in women with idiopathic premature ovarian failure.

2003

Serum inhibin A, inhibin B, pro-alphaC, and activin A levels in 30 women with idiopathic premature ovarian failure (POF), 30 postmenopausal women, and 30 age-matched fertile women were determined. Women with POF showed low levels of inhibin A and inhibin B, but not of activin A, whereas the levels of pro-alphaC were significantly higher than in postmenopausal women. Thus, the circulating level of pro-alphaC could be a marker for assessing residual ovarian function in women with POF.

endocrine systemInhibin amedicine.medical_specialtyendocrine system diseasesPrimary Ovarian InsufficiencyAndrologyOvarian functionInternal medicineMedicineHumansInhibinsProtein Precursorsreproductive and urinary physiologyInhibin bPostmenopausal womenbusiness.industryObstetrics and Gynecologyfemale genital diseases and pregnancy complicationsActivin aPostmenopauseIdiopathic premature ovarian failureEndocrinologyReproductive MedicineFemalebusinesshormones hormone substitutes and hormone antagonistsFertility and sterility
researchProduct

Primary Epithelial Ovarian Neoplasms: New Concepts Concerning Origin, Pathogenesis and Classification Based on Morphology, Immunomarkers, Molecular F…

2011

The World Health Organization (WHO) classification of ovarian tumors, which first appeared in 1983 and since then has undergone a number of revisions, is based on morphologic features as well as on the concept that each category of ovarian tumors develops from a specific ovarian cell. According to this histogenetic classification, all the epithelial ovarian neoplasms are derived from the ovarian surface epithelium and/or from ovarian inclusion cysts, which are lined by the above epithelial cells. In recent years, a new approach to morphologic data, increasing presumptive evidence that the cell of origin of most, if not all, ovarian epithelial tumors may be extraovarian, especially from fall…

endocrine systemPathologymedicine.medical_specialtyendocrine system diseasesSerous carcinomaMedicine (all)Cell of originDiseaseBiologymedicine.diseasefemale genital diseases and pregnancy complicationsTherapeutic approachOvarian tumormedicine.anatomical_structureClear cell carcinomamedicineOvarian cancerFallopian tube
researchProduct

Ovarian size and blood flow in women with polycystic ovary syndrome (PCOS) and their correlations with some endocrine parameters

2005

Objective: To determine how common polycystic ovarian morphology may be in women given the clinical diagnosis of polycystic ovary syndrome (PCOS) based on chronic anovulation and hyperandrogenism and whether certain hormonal factors correlate with ovarian morphology and blood flow. Design: Prospective study. Setting: Two academic endocrinology centers in Italy. Patient(s): Three hundred twenty-six women with PCOS and 50 age-matched and weight-matched ovulatory women. Intervention(s): Ultrasound assessment of ovarian morphology in patients and controls and ovarian blood flow and fasting hormone levels in a subset of 50 patients and matched controls. Main Outcome Measure(s): Ovarian morpholog…

endocrine systemmedicine.medical_specialtyendocrine system diseasesmedicine.drug_classPolycystic ovary syndrome ovarian size blood flow insulin testosterone inhibin Bmedicine.medical_treatmentHemodynamicsOvaryBiologyStatistics NonparametricAnovulationInsulin resistanceEndocrine GlandsInternal medicinemedicineHumansProspective StudiesGonadal Steroid Hormonesendocrine parametersAnalysis of VarianceInsulinOvaryHyperandrogenismObstetrics and GynecologyOrgan Sizemedicine.diseasePolycystic ovaryfemale genital diseases and pregnancy complicationsmedicine.anatomical_structureEndocrinologyReproductive MedicineRegional Blood FlowEstrogenpolycystic ovary syndromeFemaleHyperandrogenismpolycystic ovary syndrome; endocrine parametersAnovulation
researchProduct

Magnetic Resonance Imaging-Guided Focused Ultrasound Surgery for the Treatment of Symptomatic Uterine Fibroids

2017

Uterine fibroids, the most common benign tumor in women of childbearing age, may cause symptoms including pelvic pain, menorrhagia, dysmenorrhea, pressure, urinary symptoms, and infertility. Various approaches are available to treat symptomatic uterine fibroids. Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) represents a recently introduced noninvasive safe and effective technique that can be performed without general anesthesia, in an outpatient setting. We review the principles of MRgFUS, describing patient selection criteria for the treatments performed at our center and we present a series of five selected patients with symptomatic uterine fibroids treated with this not y…

lcsh:Medical physics. Medical radiology. Nuclear medicineInfertilitymedicine.medical_specialtyUterine fibroidslcsh:R895-920Case Report030218 nuclear medicine & medical imagingBenign tumor03 medical and health sciences0302 clinical medicineMedicineVolume reductionmedicine.diagnostic_testUrinary symptomsbusiness.industryPelvic painMagnetic resonance imagingGeneral MedicineFocused ultrasound surgerymedicine.diseasefemale genital diseases and pregnancy complicationsSurgery030220 oncology & carcinogenesisRadiologymedicine.symptomMagnetic Resonance Imaging Interventional - Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) - High-Intensity Focused Ultrasound - Ablation Techniques - Uterine Fibroids - Fertility Preservation - Uterus Sparing TreatmentSettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessCase Reports in Radiology
researchProduct